<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>infusion Archives - Gateway Psychiatric</title>
	<atom:link href="https://www.gatewaypsychiatric.com/tag/infusion/feed/" rel="self" type="application/rss+xml" />
	<link></link>
	<description>Excellent Psychiatric Care</description>
	<lastBuildDate>Thu, 24 Jun 2021 13:37:19 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://i0.wp.com/www.gatewaypsychiatric.com/wp-content/uploads/2013/06/favicon2.png?fit=32%2C32&#038;ssl=1</url>
	<title>infusion Archives - Gateway Psychiatric</title>
	<link></link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">70562394</site>	<item>
		<title>Ketamine Guidelines</title>
		<link>https://www.gatewaypsychiatric.com/ketamine-guidelines/</link>
		
		<dc:creator><![CDATA[Peter Forster]]></dc:creator>
		<pubDate>Mon, 10 Apr 2017 19:03:29 +0000</pubDate>
				<category><![CDATA[Best Practices]]></category>
		<category><![CDATA[Treatments of Depression]]></category>
		<category><![CDATA[depression]]></category>
		<category><![CDATA[guidelines]]></category>
		<category><![CDATA[infusion]]></category>
		<category><![CDATA[ketamine]]></category>
		<category><![CDATA[nasal]]></category>
		<guid isPermaLink="false">https://www.gatewaypsychiatric.com/?p=12633</guid>

					<description><![CDATA[<p>Ketamine guidelines have recently been published by&#160;American Psychiatric Association Council of Research Task Force on Novel Biomarkers and Treatments. They highlight what we know and what we don&#8217;t know about this treatment. What We Know &#8220;Several studies now provide evidence of ketamine hydrochloride’s ability to&#160;produce rapid and robust antidepressant effects in patients with mood and anxiety disorders&#160;that were previously resistant ... </p>
<div><a href="https://www.gatewaypsychiatric.com/ketamine-guidelines/" class="more-link">Read More</a></div>
<p>The post <a href="https://www.gatewaypsychiatric.com/ketamine-guidelines/">Ketamine Guidelines</a> appeared first on <a href="https://www.gatewaypsychiatric.com">Gateway Psychiatric</a>.</p>
]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">12633</post-id>	</item>
	</channel>
</rss>
